EP1244467A4 - Phosphoglycerate kinase in the treatment of disease - Google Patents

Phosphoglycerate kinase in the treatment of disease

Info

Publication number
EP1244467A4
EP1244467A4 EP00984641A EP00984641A EP1244467A4 EP 1244467 A4 EP1244467 A4 EP 1244467A4 EP 00984641 A EP00984641 A EP 00984641A EP 00984641 A EP00984641 A EP 00984641A EP 1244467 A4 EP1244467 A4 EP 1244467A4
Authority
EP
European Patent Office
Prior art keywords
disease
treatment
phosphoglycerate kinase
phosphoglycerate
kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00984641A
Other languages
German (de)
French (fr)
Other versions
EP1244467A1 (en
Inventor
Angelina J Lay
Philip John Hogg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unisearch Ltd
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Publication of EP1244467A1 publication Critical patent/EP1244467A1/en
Publication of EP1244467A4 publication Critical patent/EP1244467A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
EP00984641A 1999-12-17 2000-12-13 Phosphoglycerate kinase in the treatment of disease Withdrawn EP1244467A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ4754A AUPQ475499A0 (en) 1999-12-17 1999-12-17 Phosphoglycerate kinase in the treatment of disease
AUPQ475499 1999-12-17
PCT/AU2000/001542 WO2001043767A1 (en) 1999-12-17 2000-12-13 Phosphoglycerate kinase in the treatment of disease

Publications (2)

Publication Number Publication Date
EP1244467A1 EP1244467A1 (en) 2002-10-02
EP1244467A4 true EP1244467A4 (en) 2005-01-05

Family

ID=3818893

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00984641A Withdrawn EP1244467A4 (en) 1999-12-17 2000-12-13 Phosphoglycerate kinase in the treatment of disease

Country Status (3)

Country Link
EP (1) EP1244467A4 (en)
AU (1) AUPQ475499A0 (en)
WO (1) WO2001043767A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005016374A1 (en) * 2003-07-02 2005-02-24 Board Of Regents, The University Of Texas System Regulation of urokinase receptor expression by phosphoglycerate kinase
TWI586367B (en) * 2016-03-28 2017-06-11 蔡懷楨 Use of phosphoglycerate kinase in enhancing outgrowth of neurite and/or treating neurological disorder

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LAY A ET AL: "Phosphoglycerate kinase is secreted by tumor cells and participates in tumor angiogenesis as a disulfide reductase", JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, vol. 32, no. 3, July 2000 (2000-07-01), & XITH INTERNATIONAL VASCULAR BIOLOGY MEETING; GENEVA, SWITZERLAND; SEPTEMBER 05-09, 2000, pages 336, XP008038496, ISSN: 1122-9497 *

Also Published As

Publication number Publication date
EP1244467A1 (en) 2002-10-02
AUPQ475499A0 (en) 2000-01-20
WO2001043767A1 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
AUPQ302899A0 (en) Implants for the use in the treatment of aneurysmal disease
EE200100480A (en) Xenon for use in the treatment of nerve poisoning
MXPA03002813A (en) Compounds useful in the treatment of inflammatory diseases.
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
GB9912411D0 (en) Compounds useful in therapy
GB9912413D0 (en) Compounds useful in therapy
ZA200204493B (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders.
AU5497000A (en) Non-malignant disease treatment with ras antagonists
GB9912410D0 (en) Compounds useful in therapy
GB9912416D0 (en) Compounds useful in therapy
GB9912415D0 (en) Compounds useful in therapy
EP1244467A4 (en) Phosphoglycerate kinase in the treatment of disease
GB0029524D0 (en) Disease treatment
GB2380403B (en) Stretchers
EP1194439A4 (en) Human eag2
GB0128628D0 (en) Disease treatment
GB9911238D0 (en) Therapeutic use
HK1042039A1 (en) Use of phanquinone for the treatment or preventionof memory impairment.
AU2003230818A8 (en) Prlz regulatory elements in the treatment of disease and the discovery of therapeutics
GB9921712D0 (en) Squeeze treatment
ZA987065B (en) Small molecules useful in the treatment of inflammatory disease.
GB9919565D0 (en) Treatment of disease
GB9912184D0 (en) Therapeutic use
GB9921953D0 (en) Therapeutic use
GB9913350D0 (en) Therapeutic use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020717

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

A4 Supplementary search report drawn up and despatched

Effective date: 20041122

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 38/45 B

Ipc: 7G 01N 33/574 B

Ipc: 7A 61K 51/00 B

Ipc: 7A 61P 35/00 B

Ipc: 7G 01N 33/68 B

Ipc: 7A 61K 38/44 A

Ipc: 7A 61K 39/395 B

Ipc: 7A 61K 48/00 B

Ipc: 7A 61K 38:45 J

Ipc: 7A 61K 38/49 J

Ipc: 7A 61K 38/49 B

18D Application deemed to be withdrawn

Effective date: 20040701